{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:21:23Z","timestamp":1791998483510,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170641"],"award-info":[{"award-number":["32170641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2026A1515012932"],"award-info":[{"award-number":["2026A1515012932"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1212060013"],"award-info":[{"award-number":["2023B1212060013"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2020B1212030004"],"award-info":[{"award-number":["2020B1212030004"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbrc.2026.153893","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:23:36Z","timestamp":1778282616000},"page":"153893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor cell-derived IL-23 promotes hepatocellular carcinoma progression via an autocrine IL-23\/EGFR\/AKT signaling axis"],"prefix":"10.1016","volume":"822","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0342-5761","authenticated-orcid":false,"given":"Xuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2384-3962","authenticated-orcid":false,"given":"Yongxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2227-6190","authenticated-orcid":false,"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9581","authenticated-orcid":false,"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-9882","authenticated-orcid":false,"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-8527","authenticated-orcid":false,"given":"Yabin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153893_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153893_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2026.153893_bib3","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.3748\/wjg.v28.i46.6433","article-title":"Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma","volume":"28","author":"Niu","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153893_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153893_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: inseparable actors of cancer progression","volume":"11","author":"Suarez\u2010Carmona","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153893_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153893_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2026.153893_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.bbrc.2026.153893_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3350\/cmh.2023.0077","article-title":"The clinical management of hepatocellular carcinoma in China: progress and challenges","volume":"29","author":"Shan","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153893_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003410","article-title":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23\/IL-17 axis","volume":"9","author":"Wang","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2026.153893_bib11","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.bbadis.2018.10.004","article-title":"IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection","volume":"1864","author":"Zang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2026.153893_bib12","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0140-6736(24)01750-1","article-title":"IL-23 inhibition for chronic inflammatory disease","volume":"404","author":"Jairath","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153893_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1331217","article-title":"IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy","volume":"15","author":"Krueger","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153893_bib14","doi-asserted-by":"crossref","DOI":"10.3892\/mmr_00000223","article-title":"Expression of interleukin-23 and its receptors in human squamous cell carcinoma of the oral cavity","volume":"3","author":"Fukuda","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.153893_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002966","article-title":"Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome","volume":"9","author":"Sorrentino","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2026.153893_bib16","doi-asserted-by":"crossref","DOI":"10.3892\/or.2018.6775","article-title":"IL-23 concentration-dependently regulates T24 cell proliferation, migration and invasion and is associated with prognosis in patients with bladder cancer","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.153893_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","article-title":"IL-23 promotes tumour incidence and growth","volume":"442","author":"Langowski","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153893_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2020.11.047","article-title":"Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: implications for breast cancer progression","volume":"500","author":"Kim","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153893_bib19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/2326-6066.CIR-18-0011","article-title":"Experimental lung metastases in mice are more effectively inhibited by blockade of IL23R than IL23","volume":"6","author":"Yan","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrc.2026.153893_bib20","article-title":"Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-Kappa B induced matrix metalloproteinase 9 expression","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153893_bib21","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-18-3458","article-title":"IL23-Producing human lung cancer cells promote tumor growth via conversion of innate lymphoid cell 1 (ILC1) into ILC3","volume":"25","author":"Koh","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153893_bib22","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER20 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153893_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","article-title":"Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells","volume":"184","author":"Glassman","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153893_bib24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer \u2014 role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153893_bib25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","article-title":"Programmed cell senescence during Mammalian embryonic development","volume":"155","author":"Mu\u00f1oz-Esp\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153893_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","article-title":"The Hippo pathway in liver homeostasis and pathophysiology","volume":"16","author":"Driskill","year":"2021","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.bbrc.2026.153893_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bbrc.2026.153893_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13045-020-0845-z","article-title":"CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma","volume":"13","author":"Ma","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153893_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jare.2024.04.007","article-title":"Integrative analysis of senescence-related genes identifies robust prognostic clusters with distinct features in hepatocellular carcinoma","volume":"69","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbrc.2026.153893_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bbrc.2026.153893_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153893_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102050118","article-title":"Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing","volume":"118","author":"Deshmukh","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2026.153893_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2019.07.020","article-title":"P120 and E-cadherin: Double-edged swords in tumor metastasis","volume":"60","author":"Venhuizen","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.153893_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153893_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bbrc.2026.153893_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.153893_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153893_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115188","article-title":"Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase","volume":"28","author":"Martinez-Gualda","year":"2020","journal-title":"Bioorgan Med Chem"},{"key":"10.1016\/j.bbrc.2026.153893_bib39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.bbrc.2026.153893_bib40","doi-asserted-by":"crossref","DOI":"10.2478\/aite-2025-0020","article-title":"IL-17B inhibits hepatocellular carcinoma cell proliferation","volume":"73","author":"Pastwi\u0144ska","year":"2025","journal-title":"Arch Immunol Ther Ex"},{"key":"10.1016\/j.bbrc.2026.153893_bib41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.canlet.2016.03.012","article-title":"Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-\u03baB and JAK\/STAT3 signaling in human hepatocellular carcinoma","volume":"375","author":"Luo","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153893_bib42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2024.02.020","article-title":"Epithelial-derived interleukin-23 promotes oral mucosal immunopathology","volume":"57","author":"Kim","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2026.153893_bib43","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41586-024-07537-3","article-title":"CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation","volume":"630","author":"Ahmed","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153893_bib44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153893_bib45","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jid.2023.04.019","article-title":"IL-23\/IL-23R promote macrophage pyroptosis and T helper 1\/T helper 17 cell differentiation in mycobacterial infection","volume":"143","author":"Wang","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2026.153893_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100939","article-title":"Targeting IL-23 for the interception of obesity-associated colorectal cancer","volume":"45","author":"Madka","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrc.2026.153893_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028530","article-title":"Interleukin (IL)-12 and IL-23 and their conflicting roles in cancer","volume":"10","author":"Yan","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bbrc.2026.153893_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imcb.12851","article-title":"The cyclin\u2010dependent kinase inhibitor at7519 is a human ror\u03b3t agonist","volume":"103","author":"Kara\u015b","year":"2025","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153893_bib49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41590-024-01755-7","article-title":"IL-23 stabilizes an effector Treg cell program in the tumor microenvironment","volume":"25","author":"Wertheimer","year":"2024","journal-title":"Nat. Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:43:53Z","timestamp":1783053833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26006571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0006291X26006571"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153893","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cell-derived IL-23 promotes hepatocellular carcinoma progression via an autocrine IL-23\/EGFR\/AKT signaling axis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153893"}}